Palvella Therapeutics (PVLA) Stock Chart & Stock Price History $53.42 +2.11 (+4.11%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Palvella Therapeutics Stock Price Performance The Palvella Therapeutics (PVLA) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 345.17%. In the past month, the stock has increased 48.39%, reflecting recent market activity. As of the latest close, Palvella Therapeutics traded at $51.31 with a market cap of $567.49 million and volume of 132,069 shares. Receive PVLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Palvella Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+12.94%1 Month Performance+48.39%3 Month Performance+141.61%Year-To-Date Performance+345.17% PVLA Stock Chart for Friday, August, 22, 2025 PVLA Chart by TradingView Palvella Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$51.31$53.42+4.11%$53.93$50.94161,988 shs$590.83 million08/21/2025$50.44$51.31+1.72%$52.87$48.65132,069 shs$567.49 million08/20/2025$48.50$50.44+4.00%$51.72$46.08121,815 shs$557.87 million08/19/2025$49.55$48.50-2.12%$50.00$47.28256,685 shs$536.41 million08/18/2025$47.30$49.55+4.76%$50.22$46.43165,084 shs$548.02 million08/15/2025$46.10$47.30+2.60%$47.97$44.25190,653 shs$523.14 million08/14/2025$44.64$46.10+3.27%$47.50$41.71203,265 shs$509.68 million08/13/2025$43.21$44.64+3.31%$46.35$42.89137,735 shs$493.72 million08/12/2025$41.71$43.21+3.60%$44.04$40.92119,131 shs$477.90 million08/11/2025$40.90$41.71+1.98%$41.72$40.2278,021 shs$461.15 million Get the Latest News and Ratings for PVLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Palvella Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$39.05$40.90+4.74%$41.00$38.95106,508 shs$452.19 million08/07/2025$39.07$39.05-0.05%$39.19$37.3373,635 shs$431.89 million08/06/2025$37.52$39.07+4.13%$39.40$37.50242,689 shs$432.11 million08/05/2025$37.20$37.52+0.86%$37.80$36.9357,112 shs$414.97 million08/04/2025$36.55$37.20+1.78%$37.83$36.0079,189 shs$411.28 million08/01/2025$36.58$36.55-0.08%$36.74$34.5756,129 shs$404.10 million07/31/2025$37.44$36.58-2.30%$38.46$36.5090,854 shs$404.58 million07/30/2025$38.88$37.44-3.70%$39.20$36.85256,939 shs$414.09 million07/29/2025$39.87$38.88-2.48%$40.28$37.87332,862 shs$429.86 million07/28/2025$38.62$39.87+3.24%$40.50$37.70251,338 shs$440.96 million07/25/2025$38.63$38.62-0.03%$39.31$37.99169,749 shs$427.14 million07/24/2025$38.43$38.63+0.52%$38.63$37.2268,685 shs$427.25 million07/23/2025$36.00$38.43+6.75%$38.74$35.68331,482 shs$424.88 million07/22/2025$31.00$36.00+16.13%$36.21$31.01644,934 shs$398.16 million07/21/2025$29.51$31.00+5.05%$31.24$29.59129,238 shs$342.86 million Related Companies CGON Stock Chart MESO Stock Chart VCEL Stock Chart SRPT Stock Chart ARQT Stock Chart BEAM Stock Chart APGE Stock Chart TWST Stock Chart DYN Stock Chart SPRY Stock Chart Receive PVLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Palvella Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PVLA) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palvella Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Palvella Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access